Danni Li
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Cancer-related molecular mechanisms research
Papers in
- Oncology 21
- Peptidase Inhibition and Analysis 7
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 4
- Cancer-related Molecular Pathways 3
-
- Radiopharmaceutical Chemistry and Applications 7
- Radiomics and Machine Learning in Medical Imaging 4
- Co-authors
- Guanghe Li (3 shared papers)Dayi Zhang (3 shared papers)Elena K. Schneider‐Futschik (2 shared papers)Changjing Zuo (13 shared papers)Huagang Liu (1 shared paper)Limin Liu (1 shared paper)Gaofeng Sun (3 shared papers)Rou Li (13 shared papers)
- Journals
- Frontiers in Bioengineering and Biotechnology (3 papers)Journal of Radioanalytical and Nuclear Chemistry (3 papers)Cancer Imaging (2 papers)Frontiers in Immunology (2 papers)Journal of Translational Medicine (2 papers)
- Partner nations
- ChinaIrelandUnited States
In The Last Decade
Danni Li
48 papers receiving 501 citations
Peers
Comparison fields: 5 of 111
- Oncology 130
- Cancer Research 65
- Radiology, Nuclear Medicine and Imaging 76
- Molecular Medicine 15
- Health, Toxicology and Mutagenesis 39
Countries citing papers authored by Danni Li
This map shows the geographic impact of Danni Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danni Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danni Li more than expected).
Fields of papers citing papers by Danni Li
This network shows the impact of papers produced by Danni Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danni Li. The network helps show where Danni Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Danni Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 54 | |
| 2 | 2014 | 49 | |
| 3 | 2020 | 40 | |
| 4 | 2021 | 32 | |
| 5 | 2023 | 24 | |
| 6 | 2020 | 24 | |
| 7 | 2020 | 23 | |
| 8 | 2018 | 22 | |
| 9 | 2021 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 14 | |
| 12 | 2019 | 13 | |
| 13 | 2024 | 12 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2022 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 8 | |
| 19 | 2019 | 8 | |
| 20 | 2020 | 7 |
About Danni Li
Danni Li is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 52 papers that have together received 502 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Prostate Cancer Treatment and Research (3 papers), Cancer-related Molecular Pathways (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Oncology (130 citations), Cancer Research (65 citations), Radiology, Nuclear Medicine and Imaging (76 citations), Molecular Medicine (15 citations) and Health, Toxicology and Mutagenesis (39 citations). Danni Li has collaborated with scholars based in China, Ireland and United States. Frequent co-authors include Guanghe Li, Dayi Zhang, Elena K. Schneider‐Futschik, Changjing Zuo, Huagang Liu, Limin Liu, Gaofeng Sun, Rou Li, Xiujuan Qu and Guorong Jia. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, Journal of Radioanalytical and Nuclear Chemistry, Cancer Imaging, Frontiers in Immunology and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.